Scott Koenig

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes

K. Herold, E. Bonvini, William Hagopian, 2013, Diabetes.

Application of Dual-Affinity Re-Targeting (DART™) molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

P. Moore, S. Burke, S. Gorlatov, 2011 .